FindTrial
Sign In

Epidemiology, clinical features, pathology of HCV infection outbreak and response to interferon plus ribavirin treatment in pediatric and youngster

Epidemiology, clinical features, pathology of HCV infection outbreak and response to interferon plus ribavirin treatment in pediatric and youngster

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ENC-13003897
Enrollment
Unknown
Registered
2013-11-25
Start date
2011-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C

Interventions

Case Group:Interferon plus Ribavnirin

Sponsors

Beijing 302 Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Pediatric HCV infection cases from the epidemic area.

Exclusion criteria

Exclusion criteria: Cases meet the inclusion criteria but who are more than 18 year-old.

Design outcomes

Primary

MeasureTime frame
HCV RNA;Liver biochemical function;Abdominal B ultrasound;Anti-HCV antibody;Histology score of liver biopsy;Thyroid function;Blood routine tests;—

Secondary

MeasureTime frame
Autoantibody;Blood routine examination;Il-28B genotype;urine routine;—

Countries

China

Contacts

Public ContactShi-shu Zhu, Fu-sheng Wang

302th Hospital of PLA

302zss@sina.com+86 010 66933447

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026